Physician

Sana Ghalib, MD

According to 2025 Medicare claims, Sana Ghalib, MD (NPI: 1023460441) practices pulmonary disease in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Lawrence, OH. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1215238662; TIN: 264183569) and primary practice location at 41101-2843.

Ghalib's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 300 traditional Medicare patients, billed 892 HCPCS/CPT codes, and received $72,518 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,071 prescription claims across 177 beneficiaries totaling $1,236,293 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 433 claims. Open Payments data shows 66 records totaling $2,018. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,842 to $1,236,293. For DME billing, reported payments moved sharply higher in recent years, from $618 to $56,336.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	123	269	$22,317
2023	320	1,040	$79,422
2024	300	892	$72,518

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	17	87	$6,842
2018	46	289	$17,650
2019	43	257	$31,358
2020	21	97	$76,249
2021	20	78	$104,295
2022	74	254	$137,474
2023	176	811	$418,458
2024	177	1,071	$1,236,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$53
2020	N/R	12	$71
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	254	$39,064
2024	14	433	$64,705

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	68	179	$158
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	65	67	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	62	95	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	106	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	117	209	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	55	1,650	$713,487
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	280	11,310	$239,624
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	82	2,580	$52,718
Dupixent Syringe	Dupilumab	11	308	$41,113
Tadalafil	Tadalafil	15	450	$34,041

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	27	$27,310
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	21	$15,843
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	14	99	$12,002
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	17	$2,284
E1392	Portable oxygen concentrator, rental	Y	N/R	55	$2,166

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$2,018	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sana Ghalib, MD?

Tedicare shows public-source Medicare data for Sana Ghalib, MD (NPI 1023460441), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sana Ghalib, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sana Ghalib, MD?

Sana Ghalib, MD is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1215238662) in the available physician profile data.

Does Sana Ghalib, MD have Open Payments data?

Sana Ghalib, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.